Continuous intravenous terbutaline infusions for adult patients with status asthmaticus

M. B. O'Connell, C. Iber

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Since absorption of nebulized and subcutaneous terbutaline may be delayed or decreased during episodes of severe asthma, a preliminary trial of intravenous terbutaline was instituted in five adult patients with status asthmaticus. The terbutaline was administered as a bolus followed by a continuous infusion of 0.1-0.4 μg/kg/min. Although three patients may have received some improvement, the impact of intravenous terbutaline could not be distinguished from other concomitant therapy. All patients experienced tolerable adverse reactions. Further research to evaluate higher doses administered early in the hospital course and to determine receptor sensitivity needs to be conducted.

Original languageEnglish (US)
Pages (from-to)213-218
Number of pages6
JournalAnnals of Allergy
Issue number2 II
StatePublished - Jan 1 1990


Dive into the research topics of 'Continuous intravenous terbutaline infusions for adult patients with status asthmaticus'. Together they form a unique fingerprint.

Cite this